MX9706044A - Composicion farmaceutica para la aplicacion parenteral, que contiene un acido indol-carboxilico. - Google Patents

Composicion farmaceutica para la aplicacion parenteral, que contiene un acido indol-carboxilico.

Info

Publication number
MX9706044A
MX9706044A MX9706044A MX9706044A MX9706044A MX 9706044 A MX9706044 A MX 9706044A MX 9706044 A MX9706044 A MX 9706044A MX 9706044 A MX9706044 A MX 9706044A MX 9706044 A MX9706044 A MX 9706044A
Authority
MX
Mexico
Prior art keywords
pharmaceutical composition
indole
carboxylic acid
parenteral application
application containing
Prior art date
Application number
MX9706044A
Other languages
English (en)
Other versions
MXPA97006044A (es
Inventor
Andrea Lodi
Maria Teresa Rossato
Original Assignee
Glaxo Wellcome Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Spa filed Critical Glaxo Wellcome Spa
Publication of MX9706044A publication Critical patent/MX9706044A/es
Publication of MXPA97006044A publication Critical patent/MXPA97006044A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invencion se refiere a una composicion farmacéutica, en una forma adecuada para la administracion parenteral, que comprende una solucion del antagonista del glicina, ácido (E)-3-[2-(fenilcarbamoil)etenil]-4,6-dicloro-indol -2-carboxilico o una sal fisiologicamente aceptable del mismo, en una solucion de azucar, isotonica, que contiene un solvente orgánico miscible en agua, para el compuesto, y la formulacion tiene un pH que se encuentra en el intervalo de 7 a 9.
MXPA/A/1997/006044A 1995-02-11 1997-08-07 Composicion farmaceutica para la aplicacionparenteral, que contiene un acidoindol-carboxilico MXPA97006044A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9502695.1 1995-02-11
GBGB9502695.1A GB9502695D0 (en) 1995-02-11 1995-02-11 Pharmaceutical composition

Publications (2)

Publication Number Publication Date
MX9706044A true MX9706044A (es) 1998-06-28
MXPA97006044A MXPA97006044A (es) 1998-10-30

Family

ID=

Also Published As

Publication number Publication date
PL321734A1 (en) 1997-12-22
NO973656L (no) 1997-10-08
CA2212041A1 (en) 1996-08-15
KR19980702109A (ko) 1998-07-15
IL117098A0 (en) 1996-06-18
JPH10513464A (ja) 1998-12-22
WO1996024376A1 (en) 1996-08-15
AU4622896A (en) 1996-08-27
HUP9702448A2 (hu) 1999-10-28
NO973656D0 (no) 1997-08-08
US5886018A (en) 1999-03-23
EP0809514A1 (en) 1997-12-03
AU707220B2 (en) 1999-07-08
BR9607433A (pt) 1998-05-26
FI973280A (fi) 1997-08-08
EA199700095A1 (ru) 1998-02-26
US6020359A (en) 2000-02-01
NZ300937A (en) 1999-02-25
CZ252897A3 (cs) 1998-03-18
EA000211B1 (ru) 1998-12-24
ZA961051B (en) 1996-09-11
GB9502695D0 (en) 1995-03-29
FI973280A0 (fi) 1997-08-08

Similar Documents

Publication Publication Date Title
YU23599A (sh) Stabilizovani antihistaminski sirup
EE200100558A (et) Triarüülhappe derivaat, seda sisaldav farmatseutiline kompositsioon ja ühendi raviotstarbeline kasutamine
ES2158537T3 (es) Derivados de acidos ciclopropilalcanoicos.
BG103268A (en) Propionic acid derivatives and their application
CA2331870A1 (fr) Nouveaux composes cycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2239174A1 (en) Novel compounds with analgesic effect
CA2244785A1 (en) Pentafluorobenzenesulfonamides and analogs
EA199800290A1 (ru) (метилсульфонил) фенил-2-(5н)-фураноны в качестве ингибиторов циклооксигеназы-2
AU8772691A (en) New compounds
DE60038449D1 (de) Arzneimittelwirkstoffe mit zwei kovalent verknüpften wirkstoffgruppen (natriumkanalblocker/p2y2 rezeptor agonist) zur behandlung von schleimhäuten
RU94028888A (ru) Производные 1,3-замещенного циклоалкана и циклоалкена, смесь их изомеров или индивидуальные изомеры, их гидраты и соли, способ их получения и фармацевтическая композиция
EA200200479A1 (ru) Новые олигосахариды, их получение и содержащие их фармацевтические композиции
RU93004445A (ru) Новые 2-циано 3-гидроксиенамидные производные, способ их получения, их применение в качестве медикаментов, содержащие их фармацевтические композиции и новые полученные промежуточные продукты
ES2070994T3 (es) Profarmaco de dopamina.
IL137266A0 (en) Heterocyclic chemokine receptor antagonists and pharmaceutical compositions containing the same
EA200000023A1 (ru) Производные 2-(-4-арил или гетероарил-пиперазин-1-илметил) -1h-индола
EA199700160A1 (ru) Производные индола в качестве антагонистов eaa
ES2108129T3 (es) Nuevos derivados de pirazina, su preparacion y empleo.
CA2219359A1 (en) Hydantoin derivatives as intermediates for pharmaceutical active compounds
LV10949A (lv) Aizvietoti 4-fenil-4piperidinkarboksamidi to iegusanas panemiens farmaceitiska kompozicija
RU94038042A (ru) Производные гексагидроазепинов, фармацевтическая композиция на их основе и антипсихотропный агент
EA199700095A1 (ru) Фармацевтическая композиция для парентерального введения, содержащая индолкарбоновую кислоту
CS734389A3 (en) 4-fluoro-2-//(4-methoxy-2-pyridyl)methyl/sulfinyl/ -1h - benzimidazole, process for its production and a pharmaceutical comprising said compound as an active component
HU9800970D0 (en) Process for producing pharmaceutical compositions containing heptapeptide somatostatin derivatives of neurogene- and non-neurogene-antiflogistic and analgesic activity and peptidomimetica
EA200100984A1 (ru) Новые кристаллические формы макролидного антибиотика

Legal Events

Date Code Title Description
FA Abandonment or withdrawal